HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM

Clinical trials for HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM explained in plain language.

Never miss a new study

Get alerted when new HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM trials appear

Sign up with your email to follow new studies for HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Extended trial tests promising drug for genetic muscle disease

Disease control Completed

This study continued testing an experimental drug called AOC 1001 in adults with myotonic dystrophy type 1, a genetic muscle-wasting disease. It followed 37 participants from a previous trial to check long-term safety and see if the drug continues to work when given every 8 weeks…

Matched conditions: HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM

Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM

Get alerted when new HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM trials appear

Extended trial tests promising drug for genetic muscle disease